ArticleCritical care medicine2018

A Growing Problem of Critical Illness Due to Chimeric Antigen Receptor T-Cell Therapy.

Dusan Hanidziar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.